Aristides Capital’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,676
Closed -$207K 170
2020
Q4
$207K Buy
+1,676
New +$207K 0.07% 77